Weather
Program
Recent Quotes
My Watchlist
Indicators
Local Stocks
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Pfizer (NY: PFE )

28.93 +0.00 (+0.02%)
Streaming Delayed Price Updated: 3:46 PM EDT, Sep 26, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 25,195,539
Open 28.48
Bid (Size) 28.93 (20)
Ask (Size) 28.94 (130)
Prev. Close 28.93
Today's Range 28.31 - 28.98
52wk Range 25.20 - 34.11
Shares Outstanding 5,606,688,356
Dividend Yield 5.67%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Pfizer Voluntarily Withdraws Sickle Cell Disease Treatment Oxbryta From Global Market Due To Painful Disease Complication, Deaths
Pfizer has withdrawn Oxbryta from global markets and halted all clinical trials, citing safety concerns following clinical data that raised issues about fatal complications in sickle cell disease... 
Via Benzinga
Pfizer Tanked A $5.4 Billion Takeover. Why Crispr, Agios, Beam Could Benefit.
Pfizer stock dipped Thursday after the company voluntarily pulled its sickle cell drug, Oxbryta, from the market following patient deaths. 
Via Investor's Business Daily

Performance

YTD
-2.67%
-2.67%
1 Month
+0.05%
+0.05%
3 Month
+5.53%
+5.53%
6 Month
+4.16%
+4.16%
1 Year
-10.69%
-10.69%

More News

Read More
2 High-Yield Dividend Stocks That Can Deliver a Lifetime of Passive Income
Via The Motley Fool
3 Ultra-High-Yield Dividend Stocks to Buy Now and Hold at Least a Decade
Via The Motley Fool
Pfizer Voluntarily Withdraws All Lots of Sickle Cell Disease Treatment OXBRYTA® (voxelotor) From Worldwide Markets
From Pfizer Inc.
Via Business Wire
Pfizer Unusual Options Activity
Via Benzinga
Current Report: Pfizer (PFE)
Via Talk Markets
Pfizer Unusual Options Activity
Via Benzinga
1 Ultra-High-Yield Healthcare Stock to Buy Hand Over Fist and 1 to Avoid
Via The Motley Fool
3 Ultra-Cheap Stocks That Could Get a Boost From Fed Rate Cuts
Via The Motley Fool
Topics Economy
Exposures Interest Rates
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Ideaya Biosciences Stock Tumbles Despite Promising Data From Rare Eye Cancer Candidate
Via Benzinga
2 Beaten-Down Stocks to Buy and Hold for a Decade
Via The Motley Fool
Novo Nordisk, Chewy And FedEx Are Among Top 10 Large Cap Losers Last Week (Sept 15-Sept 21): Are The Others In Your Portfolio?
Via Benzinga
3 Dirt Cheap Stocks to Buy Right Now
Via The Motley Fool
Pfizer Advances On Its Cancer Journey
Via Benzinga
Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 3% Dividend Yields
Via Benzinga
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron KP.2-adapted COVID-19 Vaccine in the European Union
From Pfizer Inc.
Via Business Wire
How Critical Demand for Metastatic Breast Cancer Therapies is Producing a Multi-Billion Dollar Opportunity for Biotechs
Via FinancialNewsMedia
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
How Critical Demand for Metastatic Breast Cancer Therapies is Producing a Multi-Billion Dollar Opportunity for Biotechs
From FN Media Group LLC
Via GlobeNewswire
Jim Cramer Labels Moderna A 'Big Disappointment,' But Suggests Doubling Down On Another Pharma Powerhouse
Via Benzinga
3 Magnificent Dividend Stocks With Yields Above 5% to Buy Now and Hold Forever
Via The Motley Fool
Prediction: These Could Be the Best-Performing Biotech Stocks Through 2030
Via The Motley Fool
Pfizer Invites Public to View and Listen to Webcast of October 29 Conference Call with Analysts
From Pfizer Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.